CRISPR THERAPEUTIC earnings per share and revenue

1CG earnings per share for the last quarter are 0.93 CHF whereas the estimation was 0.06 CHF which accounts for 1558.80% surprise. Company revenue for the same period amounts to 169.40 M CHF despite the estimated figure of 118.67 M CHF. Estimated earnings per share for the next quarter are -1.22 CHF, and revenue is expected to reach 23.03 M CHF. Also watch annual changes over time to get a bigger picture of 1CG earnings per share and revenue dynamics.